The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of EGFR-mutant lung adenocarcinomas (AC) that transform to small cell lung cancer (SCLC).
 
Nicolas Marcoux
Honoraria - Bristol-Myers Squibb
 
Scott N. Gettinger
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol-Myers Squibb; Pfizer
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck
 
Grainne M. O'Kane
No Relationships to Disclose
 
Kathryn Cecilia Arbour
No Relationships to Disclose
 
Joel W. Neal
Consulting or Advisory Role - ARIAD/Takeda; AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - ARIAD/Takeda; ArQule; Boehringer Ingelheim; Exelixis; Genentech/Roche; Merck; Nektar; Novartis
 
Hatim Husain
Consulting or Advisory Role - Abbvie; AstraZeneca; Foundation Medicine
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Merck
 
Tracey L. Evans
Honoraria - Genentech; Genentech (I)
Consulting or Advisory Role - Genentech; Genentech (I)
Speakers' Bureau - Genentech (I)
Travel, Accommodations, Expenses - Celgene; Genentech; Genentech (I)
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck
 
Alona Muzikansky
No Relationships to Disclose
 
Philip Bonomi
Honoraria - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; pfizer; Roche/Genentech; Trovagene
Consulting or Advisory Role - AstraZeneca; Biodesix; Bristol-Myers Squibb; Lilly; Merck; Merck; Pfizer; Roche/Genentech; Trovagene
Research Funding - AstraZeneca (Inst); Biodesix (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Salvatore A. Del Prete
No Relationships to Disclose
 
Anna Wurtz
No Relationships to Disclose
 
Anna F. Farago
Honoraria - Foundation Medicine
Consulting or Advisory Role - Abbvie; Intervention Insights; Loxo; Merrimack; PharmaMar; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Loxo (Inst); Merck (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie/Stemcentrx; PharmaMar
 
Dora Dias-Santagata
No Relationships to Disclose
 
Mari Mino-Kenudson
Consulting or Advisory Role - H3 Biomedicine; Merrimack
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - Astellas Pharma; AstraZeneca; Clovis Oncology; Incyte; Lilly
 
Heather A. Wakelee
Honoraria - Novartis
Research Funding - ACEA Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Xcovery (Inst)
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merrimack (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Zofia Piotrowska
Consulting or Advisory Role - Abbvie; ARIAD/Takeda; AstraZeneca; Boehringer Ingelheim; Guardant Health; Novartis; Superdimension
Research Funding - ARIAD/Takeda (Inst); Guardant Health (Inst); Novartis (Inst)
 
Lecia V. Sequist
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genentech (Inst); Guardant Health (Inst); Incyte (Inst); Johnson & Johnson (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst)